Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.

PLoS One · 2010 · PMC2843738 · PMID 20352116

Europe PMC DOI

hedged sentence

0.0005

closest p · 0.0× alpha

0.0005

boldest claim

The sentences

highly significantp = 0.0005actually significant

At week 1 PC, this decrease in TNF-α mRNA in both groups was highly significant ( p = 0.0005 and p = 0.001 respectively, Figure 7A ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.